Selecting the Best Breast Cancer Surgeons and Hospitals in India: A Guide for Patients from Iraq

Author:- Dr. Dheeraj Bojwani Date Created:- 23-08-2026

Over the years, I have spoken with more Iraqi women facing a breast cancer diagnosis than almost any other single group of patients, and I have noticed a specific pattern worth naming plainly: many arrive already resigned to a mastectomy, simply because no one has yet told them that breast conservation, removing the tumour while preserving the breast, is very often just as safe when performed by a surgeon with the right specific training. In my experience of 24 years guiding women through this exact decision, the difference between a good outcome and a merely acceptable one in breast cancer surgery comes down to specific, checkable facts about the surgeon and hospital in front of you, not the reassurance of a glossy brochure. This guide sets out exactly what those facts are.

Healing Journeys of Iraqi Patients

Iraqi Patients Share Their Experience

Why the Choice of Breast Cancer Surgeon in India Matters as Much as the Choice of Hospital

Based on my interactions with international patients, one of the most striking and least discussed facts about breast cancer surgery in India is this: even though breast conservation surgery followed by radiotherapy has been shown repeatedly to produce survival outcomes equivalent to mastectomy, a large published Indian survey found that only 11.3 percent of women who were actually offered breast conservation went on to have it, compared with roughly 64.5 percent in the United States. This gap is not primarily about disease stage; it reflects real variation in which surgeons have the specific oncoplastic training needed to offer conservation confidently, and which default to mastectomy instead. A large multi-institutional study across three Indian centres, covering 3,453 women treated with upfront surgery, reported five-year overall survival of 94.1 percent across the full cohort, with hormone-receptor-positive cancers at 96.1 percent, HER2-positive cancers at 90.6 percent, and triple-negative cancers at 92.7 percent. These are genuinely strong, internationally competitive numbers, but they were achieved at specific, experienced centres, not as a national average, which is precisely why the identity of your surgeon and hospital matters as much as the country you choose.

How Patients from Iraq Can Verify a Breast Cancer Hospital’s Accreditation in India

The fastest filter I recommend to every Iraqi woman calling about a breast cancer diagnosis is verifiable accreditation, not marketing language. Joint Commission International, JCI, audits a hospital’s overall clinical safety systems against the same standard used across the United States and Europe, and is the credential most recognised by international patients. The National Accreditation Board for Hospitals and Healthcare Providers, NABH, is India’s own domestic equivalent, and in my experience of 24 years advising women on this exact decision, a centre holding both marks together is a meaningfully stronger signal than either alone. For breast cancer specifically, ask one further question directly: does the hospital have a dedicated breast unit with its own multidisciplinary tumour board, or is breast cancer treated within a general surgical oncology department without a specific breast sub-specialty structure? The dedicated unit model is associated with more consistent access to oncoplastic technique and reconstruction options.

The Volume and Experience Metrics That Predict Breast Cancer Surgery Outcomes in India

Based on my interactions with dozens of breast surgical units over the years, a surgeon’s specific volume in oncoplastic and breast-conserving technique, not simply general surgical oncology experience, is one of the clearest predictors of whether conservation will genuinely be offered as a safe option for your specific tumour. Ask directly, in writing:

1. What percentage of this surgeon’s early-stage breast cancer patients undergo breast conservation rather than mastectomy, and how does that compare with the roughly 60 to 65 percent breast conservation rate achieved at leading Western and Indian oncoplastic centres?
2. Does the surgeon have specific fellowship training in oncoplastic breast surgery, distinct from general surgical oncology training?
3. What is the hospital’s five-year survival rate reported separately by hormone-receptor status, HER2 status, and nodal involvement, not simply a single blended figure?
4. Is immediate breast reconstruction genuinely offered at the time of mastectomy for patients who need or choose it, or is this handled as a separate, later referral?

A surgeon confident in their own outcomes will answer these specifically. A surgeon who moves straight to recommending mastectomy without first discussing whether conservation is oncologically appropriate for your specific tumour size and location deserves a second opinion.

Questions Patients from Iraq Should Ask About the Breast Cancer Team in India

In my experience of 24 years, breast cancer treatment is never genuinely the work of one surgeon alone. Over the years, I have found that the strongest breast units bring together a breast surgical oncologist with specific oncoplastic training, a medical oncologist to guide chemotherapy and targeted or hormonal therapy based on the tumour’s specific receptor profile, a radiation oncologist for cases needing adjuvant radiotherapy, and a dedicated breast pathologist to confirm hormone receptor, HER2, and margin status accurately, since these results directly determine the treatment plan that follows surgery. Ask specifically who fills each of these roles for your case, and confirm that your case will be reviewed at a genuine multidisciplinary tumour board meeting before the final surgical plan, rather than decided by the operating surgeon in isolation.

Breast Cancer Diagnostic and Surgical Technology Standards in India That Patients from Iraq Should Check

The specific technology available changes what a surgical team can safely offer. Intraoperative margin assessment, checking the removed tissue for cancer cells at the edge while the patient is still on the operating table, reduces the chance of needing a second surgery to achieve clear margins. Oncoplastic technique itself, reshaping breast tissue at the time of tumour removal to preserve natural appearance, requires specific training beyond standard surgical oncology. For hormone-receptor and HER2 testing, ask whether the pathology laboratory processing your tissue holds its own specific accreditation, since these results determine whether targeted therapies are used correctly. Ask directly which of these specific capabilities apply to your case, not simply whether the hospital owns the equipment somewhere in the building.

Red Flags Patients from Iraq Should Watch For When Choosing a Breast Cancer Hospital in India

Over the years, certain patterns have become reliable warning signs for me. A surgeon who recommends mastectomy for every early-stage patient without individually discussing conservation, especially given how large the gap between conservation eligibility and actual conservation rates has been documented to be in parts of India, deserves direct questioning about why. A hospital that cannot report its own survival figures broken down by receptor status and nodal involvement, offering only a single blended number, is not giving you information you can meaningfully use. And a hospital that discourages a second opinion before a mastectomy, a permanent and life-changing decision, is one of the clearest signals a family can receive that something is being rushed.

Vetting a Breast Cancer Hospital in India: A Guide for Patients from Iraq

A Closing Thought for Iraqi Families

A breast cancer diagnosis deserves a treatment plan built on the specific biology of your tumour and the specific, verifiable expertise of your surgical team, not on a hospital’s general reputation or the lowest quoted price. Based on my interactions with international patients over more than two decades, the women who ask the specific questions in this guide, about oncoplastic training, conservation rates, and receptor-specific survival data, consistently make more informed decisions than those who accept a single recommendation without question. My role, and the role of any advisor a family works with, should be to help you ask these exact questions and confirm honestly that the specific surgeon and specific hospital in front of you are the right fit for your exact diagnosis. Iraq’s women deserve the same standard of scrutiny in this decision as any patient anywhere else in the world.

Sources & Further Reading

• Joint Commission International (JCI) — Accredited Organizations Directory (jointcommissioninternational.org)
• National Accreditation Board for Hospitals & Healthcare Providers (NABH), India (nabh.co)
• Indian Journal of Medical Research — Breast Conservation Surgery & Oncoplasty in India (ijmr.org.in)
• Nature Scientific Reports — Multi-Institutional Real World Data Study of Breast Cancer Outcomes in India (nature.com/srep)
• American Cancer Society — Breast Cancer Survival Rates by Subtype (cancer.org)

Frequently Asked Questions by Iraqi Patients about Selecting a Breast Cancer Surgeon and Hospital in India